Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF
Pierre Sabouret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“What’s the best antithrombotic strategy in patients with atherosclerotic stroke and concomitant AF? Thanks to Ahmed Ibrahim and Giuseppe Ando for this new MA together and to all amazing coauthors : B. Balba, A. Awashra, A. Shubieta, G. Cavolina, A. Villari”
Title: Optimal antithrombotic therapy for post-ischemic stroke patients with atrial fibrillation and atherosclerotic cardiovascular disease: A frequentist network meta-analysis
Authors: Ahmed Ibrahim, Elsayed Balbaa, Ameer Awashra, Abdalhakim Shubietah, Giulia Cavolina, Alessio Villari, Giuseppe Andò, Pierre Sabouret
Read the Full Article on Journal of the Neurological Sciences․
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 22, 2026, 16:46Congressman Don Davis: Working Toward a Better Future for Rare Disease Patients
-
Jul 22, 2026, 16:04Wolfgang Miesbach: How SUMOylation Limits AAV Gene Therapy
-
Jul 22, 2026, 15:27Obstetric APS: From Standardized Anticoagulation to Biology-Driven Precision Care
-
Jul 22, 2026, 14:31What Could Shape the Future of Hemophilia A Care? – Novo Nordisk Medical US
-
Jul 22, 2026, 10:35Ifeanyichukwu Ifechidere: We’ve Trained an Entire Generation of Clinicians to Fear The Wrong Thing About HIT
-
Jul 22, 2026, 10:16Ney Carter Borges: Understanding Pathophysiology as the Foundation of Precision Cardiovascular Care
-
Jul 22, 2026, 10:01George Cieutat: Strengthening Connections Across the Bleeding Disorders Community
-
Jul 22, 2026, 09:57Ming Y Lim: Demonstrating the Value of Upfront Emicizumab at ISTH 2026
-
Jul 22, 2026, 09:52Danny Hsu: Get to Do Some Fun Stuff at ISTH 2026